Twitter   Facebook   e-Newsletters   Podcsts   RSS Feeds   Share

181
DIOGENES®: Adverse Drug Events Database

Last Loaded on Web: Wednesday, May 01, 2013

Last Update To Bluesheet: November 1, 2003

Bluesheet Contents     PDF version

File Description Print Counterparts Geographic Coverage Terms and Conditions Limit Rates
Subject Coverage Dialog File Data Special Features Sample Record Sort
Sources Database Content DIALINDEX/OneSearch Categories Basic Index Rank
Tips Document Types Indexed Contact Additional Indexes Predefined Format Options


File Description [top]

DIOGENES®: Adverse Drug Events Database consists of two subfiles: Adverse Drug Reactions (ADR) and Adverse Event Reporting System (AERS). ADR records contain data regarding a single patient's experience with a drug or combination of drugs as reported to the U.S. Food and Drug Administration (FDA). Since 1969, the FDA has legally-mandated adverse drug reaction reports from pharmaceutical manufacturers and maintained them in their ADR system. The original reports varied greatly in detail, some providing only minimal details.

In November 1997, the ADR database was replaced by the Adverse Event Reporting System (AERS). AERS events are described on MedWatch form DGA-3500A and contain many more details than appeared on the earlier ADR records. Reports in the AERS file are evaluated by clinical reviewers in FDA's Center for Drug Evaluation. When information is unknown, it is omitted.

Vaccines are reported in a separate system and are not included in ADR data.



Tips [top]

USE FILE 181

to monitor reported adverse drug reactions.

SEARCH /NA or NA=

to find suspect or concomittant drug names:

     S INSULIN/NA
     S NA=WARFARIN

SEARCH /CO or CO=

to find specific drug manufacturers or reporting manufacturers:

     S BAYER/CO

USE /AER

to restrict to more recent AER data:

     S BETASERON/AER


Subject Coverage [top]

The scope of DIOGENES®: Adverse Drug Events Database is FDA-related data regarding drugs as reported by drug manufacturers, individuals, health professionals, and medical studies. Records provide:

  • FDA Report Number and FDA Receipt Date
  • Manufacturer's Report Number
  • Drug Name and Reaction Date
  • Patient age and sex
  • Reported reactions and Outcomes
  • Concomitant drugs

Records also contain manufacturer name, dosage, administration route, and drug lot number, when this information is known.



Sources [top]

Data included in ADR records is drawn from the ADR database, which began in 1969. From November 1997 onward, the information is taken from the AERS database, as described above.



Print Counterparts [top]

  • None


Dialog File Data [top]

Dates Covered: ADRs - 1969 through October 1997; AERs - November 1997 to 2008
File Size: 4,223,207 records
Update Frequency: Closed


Database Content [top]

  • Directories


Document Types Indexed [top]

  • Government Documents


Geographic Coverage [top]

  • US Only


Geographic Restrictions [top]

  • None


Special Features [top]

  • ERA Available
  • KWIC and HILIGHT Available


DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME
PHARMR Pharmacology + RINGDOC-Files
PHARMREG Pharmaceutical Regulation
REGS Regulations
SAFETY Safety
TOXICOL Toxicology


Contact [top]

DIOGENES®: Adverse Drug Events Database is produced by the FOI Services, Inc. Questions concerning file content should be directed to:

FOI Services, Inc.
704 Quince Orchard Road
Suite 275
Gaithersburg, MD 20878

Telephone: 301-975-9400
Fax: 301-975-0702
E-Mail: diogenes@foiservices.com


Terms and Conditions [top]

All information and record identification in DIOGENES® Adverse Drug Events Database is fully protected by copyright. Reproduction or photocopying even for internal use without the publisher's permission is prohibited. While every effort has been made to ensure that the information in the database is correct, FOI Services, Inc. cannot accept any responsibility for errors or omissions.


Dialog Standard Terms & Conditions apply.


SAMPLE RECORD [top]

    DIALOG(R)File 181:DIOGENES(r) Adverse Drug Events 
    (c) 2003 The Dialog Corporation. All rts. reserv. 
     
    0002965633 
  AA=  FDA Report number:    4058668 
  PD=,PY=  FDA Receipt Date:     October 28, 2002 
     
     
    Report Title: 
  /TI,/NA,NA=,/NS,NS=  AERS Drug Report. 1 Suspect Drug(s): BETASERON. Total 6 Drug(s) Cited. 
  /CO,CO=,/SM,SM=  Sending Manufacturer: BERLEX LABORATORIES 
  FS=  ADR/AER:              AER 
  RC=  Report Code:          Expedited (15-day: reported by manufacturer) 
  RS=  Report Source:        Consumer; Health Professional; Physician 
    Date on Report:       October 23, 2002 
    Source/update date:   FDA AERS list (20030821) 
  RN=  Manufacture Report#:  USA-2002-002832 
    FDA Image ID:         4058668-8 
    Initial/follow-up:    Followup 
    Follow-up sequence#:  2 
  CN=  Case number:          3837144 
    Electronic submission:No 
     
  RD=,RY=  Reaction Date:  January 7, 2002 
  RE=  Reactions:      GLIOBLASTOMA 
  OT=  Outcomes:       Death 
    Death Date:     20020716 
     
    Patient Information: 
  AG=  Age:                  53 Years 
  SX=  Sex:                  Female 
    Weight:               46.7 KG 
    Drug Information: 
  /NA,NA=    Primary Suspect: BETASERON; Manufacturer Reported: Unknown; Dosage 
  /TX      Reported: 8 MIU, EVERY 2D, SUBCUTANEOUS; Reported Route: SUBCUTANEOUS; 
        N/A Dechallenge Result; N/A Rechallenge Result; Validated Trade Name 
        Drug Name Source; Unknown Lot Number; Unknown Expiration; Therapy Dates 
        (Start-End): 19991129-20020716 
  /NA,NA=    Concomitant: CLONIDINE; Manufacturer Reported: Unknown; Dosage Reported: 
  /TX      Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown 
        Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot 
        Number; Unknown Expiration 
  /NA,NA=    Concomitant: FUROSEMIDE; Manufacturer Reported: Unknown; Dosage Reported: 
  /TX      Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown 
        Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot 
        Number; Unknown Expiration 
  /NA,NA=    Concomitant: MIACALCIN; Manufacturer Reported: Unknown; Dosage Reported: 
  /TX      Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown 
        Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot 
        Number; Unknown Expiration 
  /NA,NA=    Concomitant: KLOR-CON; Manufacturer Reported: Unknown; Dosage Reported: 
  /TX      Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown 
        Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot 
        Number; Unknown Expiration 
  /NA,NA=    Concomitant: CALCIUM (CALCIUM); Manufacturer Reported: Unknown; Dosage 
  /TX      Reported: Unknown; Reported Route: Unknown; Unknown Dechallenge Result; 
        Unknown Rechallenge Result; Verbatim Drug Name Drug Name Source; 
        Unknown Lot Number; Unknown Expiration 
     


BASIC INDEX [top]

SEARCH
SUFFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
None None All Basic Index Fields Word S SUSPECT
/CO CO Company Name1 Word S BERLEX/CO
/NA DI Drug Name1,2 Word S BETASERON/NA
/NS DI Named Suspect Drug1 Word S BETASERON/NS
/SM SM Sending Manufacturer1,3 Word S BERLEX/SM
/TI TI Title Word S BETASERON/TI
/TX TX,NT Text of Drug Information and Notes4 Word S SUBCUTANEOUS/TX

1 Searchable in the Basic Index and in the Additional Indexes.

2 Includes Named Suspect Drug (NS=).

3 Present only in AER subfile records.

4 Notes are present only in ADR subfile records.


ADDITIONAL INDEXES [top]

SEARCH
PREFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
AA= AA Supplier Accession Number/FDA Report Number Phrase S AA=4058668
AG= AG Age Phrase S AG=030:040
None AZ DIALOG Accession Number
CN= CN Case Number Phrase S CN=3837144
CO= CO Company Name1 Phrase S CO=BERLEX LAB?
None DD Death Date
None DI Drug Information
None DR Date on Report
FI= FI Follow-up/Initial Report Phrase S FI=INITIAL
FS= FS Subfile/File Segment Phrase S FS=AER
LA= LA Language Phrase S LA=ENGLISH
NA= DI Drug Name1,2 Phrase S NA=BETASERON?
NS= DI Named Suspect Drug1 Phrase S NS=BETASERON?
OT= OT Outcome Phrase S OT=(DEATH OR DIED)
PD= PD FDA Receipt Date Phrase S PD=20021028
PY= PY FDA Receipt Year Phrase S PY=2002
RC= RC Report Code Phrase S RC=EXPEDITED?
RD= RD Reaction Date Phrase S RD=20020107
RE= RE Reaction Phrase S RE=GLIOBLASTOMA
RN= RN Manufacturer Report Number Phrase S RN=USA-2002-002832
None RP Report Type
RS= RS Report Source Phrase S RS=CONSUMER
RY= RY Reaction Year Phrase S RY=2002
SM= SM Sending Manufacturer1,3 Phrase S SM=BERLEX?
None SO Source Information
SX= SX Sex Phrase S SX=FEMALE
UD= None Update Phrase S UD=9999
None WT Weight


LIMIT [top]

SUFFIX FIELD NAME EXAMPLES
/ADR ADR Subfile Record S S2/ADR
/AER AER Subfile Record S S2/AER
/YYYY Publication Year S S3/2002


SORT [top]

SORTABLE FIELDS EXAMPLES
AA, NA, PD, PY SORT S6/ALL/PY
PRINT S3/5/1-24/NA


RANK [top]

RANK FIELDS EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. RANK CO S3


USER-DEFINED FORMAT OPTIONS [top]

User-defined formats may be specified using the display codes indicated in the Search Options tables. TYPE S3/NA,TI,RE/1-5


PREDEFINED FORMAT OPTIONS [top]

NO.
DIALOGWEB
FORMAT
RECORD CONTENT
1 -- DIALOG Accession Number
2 -- Suspect Drug Name, Title, Dates, Report Code, Report Source, Manufacturer Report Number, FDA Request Number, Sending Manufacturer, Reaction Data and Outcomes, and Patient Information
3 Medium Suspect Drug Name, Title, Dates, Report Code, Report Source, Manufacturer Report Number, FDA Request Number, and Sending Manufacturer
4 -- Full Record with Tagged Fields
5 -- Full Record with Drug Information Text (includes if known Concomittant Drugs, Manufacturer Reported, Dosage, Reported Route, and Therapy Dates)
6 Free Suspect Drug Name, Title, and FDA Receipt Date
7 -- Suspect Drug Name, Title, Dates, Report Code, Report Source, Manufacturer Report Number, FDA Request Number, Sending Manufacturer, Reaction Data and Outcomes, and Patient Information
8 Short Title and Sending Manufacturer
9 Full Full Record with Drug Information Text (includes if known Concomittant Drugs, Manufacturer Reported, Dosage, Reported Route, and Therapy Dates)
K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats


DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES
DIALOG Accession Number TYPE 120491/5
DISPLAY 119604/TI
PRINT 117590/3


Rates [top]

Rates For File: DIOGENES®:  Adverse Drug Events Database[181]
Cost per DialUnit:                $16.96
Cost per minute:                   $3.83
Rank Elements                      $0.04

Format    Types   Prints
     1    $0.00    $0.00
     2    $1.50    $1.50
     3    $1.50    $1.50
     4    $1.50    $1.50
     5    $1.50    $1.50
     6    $0.00    $0.00
     7    $1.50    $1.50
     8    $1.50    $1.50
     9    $1.75    $1.75
KWIC95    $1.50       NA
KWIC96    $1.50       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
[top]



All contents Copyright © Dialog, LLC. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.